PERRIGO Co plc
PRGO- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001585364
No open-market purchases or sales by PERRIGO Co plc insiders were filed in the last 90 days; 340 institutions reported holding it in 13F filings for Q2 2026, worth $1.67B in total; Maverick Capital is the only superinvestor holding it.
Superinvestors holding PRGO, Q2 2026
1 superinvestor reports holding PERRIGO Co plc on Form 13F, worth $4.66M in total. Weight is PERRIGO Co plc's share of each 13F portfolio; actions compare shares with Q1 2026.
| Superinvestor | % of portfolio | Shares | Value | vs. previous quarter |
|---|---|---|---|---|
| Maverick CapitalLee Ainslie | <0.1% | 448,053 | $4.66M | New |
Moves by quarter
Superinvestors that opened, added to, trimmed or sold out of PRGO each quarter, comparing shares with the quarter before. A superinvestor that didn't file for a quarter isn't listed, and isn't counted as selling.
Q2 2026
1 superinvestor holding at quarter end
Q4 2025
0 superinvestors holding at quarter end
- Sold out
- Maverick Capital
Q3 2025
1 superinvestor holding at quarter end
Q4 2024
0 superinvestors holding at quarter end
- Sold out
- Maverick Capital
Q3 2024
1 superinvestor holding at quarter end
- Added
- Maverick Capital (+16.3%)
Q2 2024
1 superinvestor holding at quarter end
Q2 2023
0 superinvestors holding at quarter end
- Sold out
- Maverick Capital
Q1 2023
1 superinvestor holding at quarter end
- Added
- Maverick Capital (+2,379.1%)
Q4 2022
1 superinvestor holding at quarter end
Q2 2022
0 superinvestors holding at quarter end
- Sold out
- Viking Global Investors
Q1 2022
1 superinvestor holding at quarter end
- New
- Viking Global Investors
- Sold out
- Maverick Capital
Q4 2021
1 superinvestor holding at quarter end
- Reduced
- Maverick Capital (−97.6%)
Q3 2021
1 superinvestor holding at quarter end
- Added
- Maverick Capital (+6,291.0%)
Q2 2021
1 superinvestor holding at quarter end
- Added
- Maverick Capital (+126.3%)